Skip to content
Resolve Egypt Restructuring & Special Situations Marketplace
RES-0001 Due Diligence

Egyptian Pharmaceutical Distribution Opportunity

Pharmaceutical Distribution · Pharmaceuticals | Egypt (nationwide)

Liquidity Pressure / Working Capital Stress / Operational RestructuringSituation
EGP 200 – 500 millionCapital Requirement
EGP 1 – 3 billionRevenue
Working Capital / Debt Refinancing / Minority InvestmentTransaction

Business Overview

A national pharmaceutical wholesaler serving retail pharmacies, hospitals and clinics through a network of regional depots, with a licensed cold chain and a proprietary ordering platform used by several thousand pharmacy customers.

Situation Overview

A high-volume, low-margin distribution model carrying an extended receivables book. Receivable days lengthened materially while payment terms to principals stayed fixed, creating a liquidity gap that is structural to the working capital cycle rather than a function of trading losses.

RESTRICTED

Extended information

Extended situation detail, investment thesis and turnaround assessment are available to verified investors.

Sign in or register

Request Confidential Access

Company identity, exact financial position, debt structure and the restructuring plan are released to qualified investors under a confidentiality undertaking, opportunity by opportunity.

Sign in to request access

Resolve Egypt is an independent private commercial platform. It is not affiliated with, endorsed by, or acting on behalf of any ministry, governmental authority, judicial authority, Economic Court or regulatory authority.

Information provided through the platform does not constitute investment advice. Investors remain responsible for conducting their own financial, commercial, legal and tax due diligence.